{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:26:13Z","timestamp":1791919573580,"version":"4.3.4"},"reference-count":8,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.leukres.2010.03.007","type":"journal-article","created":{"date-parts":[[2010,4,3]],"date-time":"2010-04-03T08:33:34Z","timestamp":1270283614000},"page":"1103-1106","source":"Crossref","is-referenced-by-count":15,"title":["SLC6A4 expression and anti-proliferative responses to serotonin transporter ligands chlomipramine and fluoxetine in primary B-cell malignancies"],"prefix":"10.1016","volume":"34","author":[{"given":"Anita","family":"Chamba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle J.","family":"Holder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth F.","family":"Jarrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley","family":"Shield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai M.","family":"Toellner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark T.","family":"Drayson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas M.","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2010.03.007_bib1","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1182\/blood.V99.7.2545","article-title":"5-Hydroxytryptamine drives apoptosis in biopsylike Burkitt lymphoma cells: reversal by selective serotonin reuptake inhibitors","volume":"99","author":"Serafeim","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.03.007_bib2","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1096\/fj.04-3477fje","article-title":"The serotonin transporter (SLC6A4) is present in B-cell clones of diverse malignant origin: probing a potential anti-tumor target for psychotropics","volume":"19","author":"Meredith","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.leukres.2010.03.007_bib3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jneuroim.2008.07.014","article-title":"Characterisation of the endogenous human peripheral serotonin transporter SLC6A4 reveals surface expression without N-glycosylation","volume":"204","author":"Chamba","year":"2008","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.leukres.2010.03.007_bib4","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1182\/blood-2002-07-2044","article-title":"Selective serotonin reuptake inhibitors directly signal for apoptosis in biopsy-like Burkitt lymphoma cells","volume":"15","author":"Serafeim","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.03.007_bib5","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.semcancer.2007.12.007","article-title":"Harnessing serotonergic and dopaminergic pathways for lymphoma therapy: evidence and aspirations","volume":"18","author":"Barnes","year":"2008","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.leukres.2010.03.007_bib6","doi-asserted-by":"crossref","first-page":"13485","DOI":"10.1073\/pnas.0605993103","article-title":"Dopamine targets cycling B cells independent of receptors\/transporter for oxidative attack: implications for non-Hodgkin's lymphoma","volume":"103","author":"Meredith","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.leukres.2010.03.007_bib7","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1002\/eji.200323357","article-title":"Naive and memory B cells respond differentially to T-dependent signaling but display an equal potential for differentiation toward the centroblast-restricted CD77\/globotriaosylceramide phenotype","volume":"33","author":"Gagro","year":"2003","journal-title":"Eur J Immunol"},{"issue":"6","key":"10.1016\/j.leukres.2010.03.007_bib8","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.bcp.2008.02.009","article-title":"In response to selective serotonin reuptake inhibitors\u2014a new modality for the treatment of lymphoma\/leukaemia? by C. Schuster, et al. [Biochem Pharmacol 2007;74:1424\u20131435]","volume":"75","author":"Gordon","year":"2008","journal-title":"Biochem Pharmacol"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212610001426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212610001426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,27]],"date-time":"2019-05-27T23:26:14Z","timestamp":1558999574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212610001426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":8,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0145212610001426"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2010.03.007","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}